Clinical trial
A Study of Protein Metabolism, Microbiome and Investigational Probiotic Use in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT03324399 is registered in ClinicalTrials.gov with Avera McKennan Hospital & University Health Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Protein Metabolism, Microbiome and Investigational Probiotic Use in Patients With Amyotrophic Lateral Sclerosis (ALS)
- Lead sponsor
- Avera McKennan Hospital & University Health Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 1, 2017
- Completion date
- June 26, 2019
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.